Bovine Respiratory Disease Treatment Market Continues To Grow Owing To the Demand from Various Cattle Owners to Protect Their Cattle and Supply High-Quality Meat to Consumers

 


Bovine respiratory disease treatment is a condition caused by exposure to contaminated tapeworm segments, which are found in raw or semi-raw dairy products and meat. Exposure to live or raw eggs can cause an infection and should be avoided to prevent worsening the situation. Treatment is relatively simple and consists of identifying infected eggs, removing them from the body, and then treating the infection through the administration of antibiotics. This process requires daily applications of a medicated spray and is effective for mild to moderate cases. More severe cases may require a course of intravenous antibiotics followed by a vapor rub, which helps to loosen the congested and hard lumpy mucus that often accompanies the disease. Topical corticosteroids may also be prescribed in severe cases to relieve symptoms and reduce the number of fluids in the lungs.

Market Dynamics                                  

The main driving factor influencing the bovine respiratory disease treatment market is the rapid increase of this disease. The rapid expansion of the cattle population and changing environmental conditions are estimated to propel the market growth. According to a report by Beef Cattle Research Council, Bovine respiratory diseases result in 65-80% of morbidity and 45-75% of mortality rates in the cattle yards in the U.S. Moreover, rising awareness among the consumers related to healthy meat consumption, new environmental protection rules, and animal health monitoring practices are expected to boost the growth of the bovine respiratory disease treatment market.

However, the absence of awareness related to meat consumption in developing nations is the main restraining factor hindering market growth. Few complications are related to Bovine respiratory disease treatment. Animals that are suffering from bovine respiratory diseases sometimes show signs of weight loss, depression, mucopurulent or purulent nasal discharge, cough, and increased body temperature. The diagnosis after identifying these physical symptoms is tough owing to the similarities of the symptoms to other bacteria-caused diseases. Hence this factor is estimated to hinder the market growth.

This market is distributed in five regions that include North America, Europe, Asia-Pacific, Middle East, and Africa, and Latin America. Among these North America is estimated to hold a significant share of the bovine respiratory disease treatment market owing to the number of factors such as clusters of a bovine animal, increase in bovine respiratory diseases, and extensive expenditure on bovine health awareness. In the U.S. heavy amount of meat is consumed which comprises mainly of poultry and beef, and this factor is expected to drive the Bovine respiratory disease treatment market in the region. For instance, according to the North American Meat Institute, in 2019, the U.S. total consumption of beef amounted to approximately US$ 27.3 billion. The Asia Pacific is estimated to witness significant growth in the Bovine respiratory disease treatment market owing to the presence of a large number of animals and increasing awareness related to animal welfare in the region.

Competitive Analysis

Key players in the bovine respiratory disease treatment market include Bimeda Animal Health, Vetoquinol, Elanco, Boehringer Ingelheim GmbH, Virbac Group, Merck & Co., Inc., Bayer AG, and Zoetis Inc.

In September 2018, Boehringer Ingelheim GmbH introduced Bovalto Respi Intranasal, which is a new respiratory vaccine used in the treatment against viruses such as Bovine Respiratory Syncytial Virus (BSRV) and Parainfluenza 3 Virus in cattle. Likewise, in April 2018, VIDO - InterVac announced about developing a new vaccine that can protect cattle in Africa from bovine pleuropneumonia (CBPP).


Comments

Post a Comment

Popular posts from this blog

Increasing Consumption and Production of Fertilizers to Upsurge the Growth of the Agrochemicals Market

Image
  Agrochemical products are those chemicals that are used to increase the production of an agricultural environment. Agrochemical chemicals typically include pesticides, fertilizers, lime precursors, acidizing and alkalizing agents (all of which are designed to alter the normal pH level of the soil), lime stabilizers, and other nutrients that are required for plant growth. These chemicals are widely used by farmers and are crucial to the functioning of modern agriculture. The use of these chemicals presents a number of concerns both from the perspective of the environment and the human body. The increasing need for improving crop production due to the growing concern of food security and lack of arable land is fueling the growth of agrochemicals market . Growing advancement in technology is raising adoption of advanced and sustainable farming practices which is again propelling the growth of the market. The increasing population coupled with the growing usage of fertilizers around th
Read more

High Prevalence of Cancer and R&D in Anti-Cd39 Antibodies to Augment Growth of Anti-body Coupled T Receptor Therapy Market

Image
  Antibody-Coupled T cell Receptor (ACTR) is an autologous engineered T cell therapy that combines the Fc receptor, CD16, with endogenous T cell signaling and costimulatory domains. It is combined with tumor-targeting antibodies to exert potent anti-tumor immune responses and eliminate cancerous cells. ACRT has demonstrated potential in the treatment of multiple myeloma and HER2+ advanced cancers. Market Dynamics R&D in anti-CD39 antibodies is expected to propel growth of the Anti-body Coupled T Receptor Therapy Market . For instance, in December 2020, Arcus Biosciences, Inc. expanded its existing partnership with WuXi Biologics, a developer of biologics technology platforms, for R&D in anti-CD39 antibodies using WuXi Bio’s proprietary technology. Moreover, high prevalence of cancer is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 canc
Read more

Increasing Prevalence of Muscular Dystrophy to Augment the Muscular Dystrophy Treatment Market Growth

Image
  Muscular dystrophy is a common disease that causes muscles to become weaker and unable to continue to develop properly. Because it often affects young children as well as adults, it can be difficult to detect. However, once symptoms are noticed, steps must be taken to prevent the disease. There are many treatment options available for muscular dystrophy. The severity of the disease will determine what type of treatment is best for your situation. Muscular dystrophy treatment involves breathing aids, therapy, surgery, or medication, which may help maintain function, but life span is often shortened. Market Dynamics: Increasing prevalence or incidence of muscular dystrophy, especially in the North America, is expected to propel the growth of the muscular dystrophy treatment market . For instance, one in 3,500 male babies born worldwide are affected with Duchenne muscular dystrophy (DMD), according to the National Organization for Rare Disorders. Moreover, in 2019, around 349 new ca
Read more